摘要 Objective: To investigate the urodynamic study (UDS) patterns, obstruction status, continence status, and their correlations among neurologically intact women with lower urinary tract symptoms (LUTS) through an epidemiological and logistic regression analyses. Methods: We retrospectively analyzed the UDS data of 3265 neurologically intact women with LUTS (2002-2014). Five UDS patterns were identified: normo-active detrusor/sphincter (NA, or DSI, detrusor/sphincter intact), idiopathic detrusor overactivity (IDO), idiopathic sphincter overactivity (ISO), IDO + ISO, and detrusor underactivity (DUA). Analyses of UDS pattern distribution and stratification were performed (based on a modification of the European Urological Association-Madersbacher classification system), and their correlations with bladder outlet obstruction (BOO) and stress urinary incontinence (SUI) status were evaluated via logistic regression analysis. Results: NA, IDO, IDO + ISO, ISO, and DUA were noted in 927 (28.4%), 678 (20.8%), 320 (9.8%), 689 (21.1%), and 651 (19.9%) cases, respectively. Moreover, storage, storage + voiding, and voiding symptoms were noted in 62.4%, 21.1%, and 16.5% cases, respectively, whereas BOO and SUI were observed in 12.1% and 29.0% cases, respectively. The risk factors for BOO included NA, IDO, ISO, and IDO + ISO, whereas the protective factors against BOO included storage symptoms, SUI, storage + voiding symptoms, and complaint duration within 1-12 months. NA was the only risk factor for SUI, whereas BOO, storage + voiding symptoms, IDO, and storage symptoms were protective factors for SUI. Conclusion: Five UDS patterns were identified among neurologically intact women with LUTS. Functional abnormalities of the detrusor and/or sphincter were the main causes of LUTS, and were correlated with the BOO or SUI status. Thus, the UDS pattern can provide additional information regarding the risk factors for BOO or SUI status, as compared to symptomatic typing.
Abstract: Objective: To investigate the urodynamic study (UDS) patterns, obstruction status, continence status, and their correlations among neurologically intact women with lower urinary tract symptoms (LUTS) through an epidemiological and logistic regression analyses. Methods: We retrospectively analyzed the UDS data of 3265 neurologically intact women with LUTS (2002-2014). Five UDS patterns were identified: normo-active detrusor/sphincter (NA, or DSI, detrusor/sphincter intact), idiopathic detrusor overactivity (IDO), idiopathic sphincter overactivity (ISO), IDO + ISO, and detrusor underactivity (DUA). Analyses of UDS pattern distribution and stratification were performed (based on a modification of the European Urological Association-Madersbacher classification system), and their correlations with bladder outlet obstruction (BOO) and stress urinary incontinence (SUI) status were evaluated via logistic regression analysis. Results: NA, IDO, IDO + ISO, ISO, and DUA were noted in 927 (28.4%), 678 (20.8%), 320 (9.8%), 689 (21.1%), and 651 (19.9%) cases, respectively. Moreover, storage, storage + voiding, and voiding symptoms were noted in 62.4%, 21.1%, and 16.5% cases, respectively, whereas BOO and SUI were observed in 12.1% and 29.0% cases, respectively. The risk factors for BOO included NA, IDO, ISO, and IDO + ISO, whereas the protective factors against BOO included storage symptoms, SUI, storage + voiding symptoms, and complaint duration within 1-12 months. NA was the only risk factor for SUI, whereas BOO, storage + voiding symptoms, IDO, and storage symptoms were protective factors for SUI. Conclusion: Five UDS patterns were identified among neurologically intact women with LUTS. Functional abnormalities of the detrusor and/or sphincter were the main causes of LUTS, and were correlated with the BOO or SUI status. Thus, the UDS pattern can provide additional information regarding the risk factors for BOO or SUI status, as compared to symptomatic typing.
基金资助: The authors would like to thank Zhilian Min, Youhua Zhu, Yacheng Yao, Jizhong Ren, Yushan Liu, and Yi Gao for their outstanding efforts in data management; Zixing Zhang for the development of decoction of Chinese medicinal herbs; Xingyi Zhang for the help with image creation; Wei Qian and Jin Wang for help with statistical analysis; and Cheng Zhong, Yana Liu and Xingwei Liu for their constant technical support.
通讯作者:
Chuangyu Qu, Lei Yin
E-mail: qu_cy@sohu.com;yin202@163.com
引用本文:
Linhui Wang, Cunzhou Wang, Chuangyu Qu, Lei Yin, Danfeng Xu, Xingang Cui, Bing Liu. Relationship between urodynamic patterns and lower urinary tract symptoms in Chinese women with a non-neurogenic bladder[J]. Asian Journal of Urology, 2016, 3(1): 10-19.
Linhui Wang, Cunzhou Wang, Chuangyu Qu, Lei Yin, Danfeng Xu, Xingang Cui, Bing Liu. Relationship between urodynamic patterns and lower urinary tract symptoms in Chinese women with a non-neurogenic bladder. Asian Journal of Urology, 2016, 3(1): 10-19.
Zhang L, Zhu L, Xu T, Lang JH, Li ZA, Gong J, et al. A population-based survey of the prevalence, potential risk factors, and symptom-specific bother of lower urinary tract symptoms in adult Chinese women. Eur Urol 2015;68:97-112.
[2]
Abrams P, Smith AP, Cotterill N. The impact of urinary incontinence on health-related quality of life (HRQoL) in a realworld population of women aged 45-60 years: results from a survey in France, Germany, the UK and the USA. BJU Int 2015; 115:143-52.
[3]
Kuo HC. Videourodynamic characteristics and lower urinary tract symptoms of female bladder outlet obstruction. Urology 2005;66:1005-9.
[4]
Stöhrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, del Popolo G, Kramer G, et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol 2009;56:81-8.
[5]
Qu CY, Xu DF, Wang CZ, Chen J, Yin L, Cui X. Anal sphincter electromyogram for dysfunction of lower urinary tract and pelvic floor. In: Mizrahi J, editor. Advances in applied electromyography. Rijeka: InTech; 2011. p. 161-88.
[6]
Irwin DE, Milsom I, Kopp Z, Abrams P, Artibani W, Herschorn S. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur Urol 2009;56:14-20.
[7]
Xu DF, Cui XG, Qu CY, Yin L, Wang CZ, Chen J. Urodynamic pattern distribution among aged male patients with lower urinary tract symptoms suggestive of bladder outlet obstruction. Urology 2014;83:563-9.
[8]
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report for the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-78.
[9]
Xu DF, Qu CY, Meng H, Ren JZ, Zhu YH, Min ZL, et al. Dysfunctional voiding confirmed by transdermal perineal electromyography, and its effective treatment with baclofen in women with lower urinary tract symptoms: a randomized double-blind placebo-controlled crossover trial. BJU Int 2007; 100:588-92.
[10]
Qu CY, Xu DF. Comprehensive urodynamics: being devoted to clinical urologic practice. World J Clin Urol 2014;3:96-112.
[11]
Zhang P, Wu ZJ, Xu L, Yang Y, Zhang N, Zhang XD. Bladder neck incision for female bladder neck obstruction: long-term outcomes. Urology 2014;83:762-7.
[12]
Jhang JF, Jiang YH, Kuo HC. Transurethral incision of the bladder neck improves voiding efficiency in female patients with detrusor underactivity. Int Urogynecol J 2014;25:671-6.
[13]
Peeters K, Sahai A, De Ridder D, Van der Aa. Long-term followup of sacral neuromodulation for lower urinary tract dysfunction. BJU Int 2014;13:789-94.
[14]
Xu DF, Zhang S, Wang CZ, Li J, Qu CY, Cui XG, et al. Lowfrequency electrotherapy for female patients with detrusor underactivity due to neuromuscular deficiency. Int Urogynecol J 2012;23:1007-15.
[15]
Blaivas JG, Groutz A. Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology. Neurourol Urodyn 2000;19:553-64.
[16]
Blaivas JG, Chancellor MB, Weiss J, Verharren M. Atlas of urodynamics. Glossary and abbreviations. 2nd ed. Blackwell Publishing; 2007. p. 7.
[17]
Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 2010;21:5-26.
[18]
Chen SF, Jiang YH, Jhang JF, Lee CL, Kuo HC. Bladder management and urological complications in patients with chronic spinal cord injuries in Taiwan. Tzu Chi Med J 2014;26:25-8.
[19]
Biers S, Thiruchelvam N. Bladder pain syndrome: contemporary management and future strategies. J Clin Urol 2014;7: 8-19.
[20]
Nager CW, Brubaker L, Litman HJ, Zyczynski HM, Varrer E, Amundsen C, et al. A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med 2012;366: 1987-97.
[21]
Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. Eur Urol 2015;67:1142-51.
[22]
Mc Connell JD. Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia? Urology 1994;44:156-8.
[23]
Auffenberg GB, Gonzalez CM, Wolf JS, Clemens JQ, Meeks W, McVary KT. An observational analysis of provider adherence to AUA guidelines on the management of benign prostatic hyperplasia. J Urol 2014;192:1483-8.
[24]
Haylen BT, Krishnan S, Schulz S, Verity L, Law M, Zhou J, et al. Has the true prevalence of voiding difficulty in urogynecology patients been underestimated? Int Urogynecol J 2007;18: 53-6.
Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, et al. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol 2014;65:389-98.
[27]
Hinman Jr F. Nonneurogenic neurogenic bladder (the Hinman syndrome)e15 years later. J Urol 1986;136:769-77.
[28]
Nevéus T, von Gontard A, Hoebeke P, Hjalmas K, Bauer S, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardization Committee of the International Children's Continence Society. J Urol 2006;176:314-24.
[29]
Sacco E, Bientinesi R. Innovative pharmacotherapies for women with overactive bladder: where are we now and what is in the pipeline? Int Urogynecol J 2015;26:629-40.
[30]
Wang YL, Hu H, Xu KX, Wang XF, Na YQ, Kang XP. Prevalence, risk factors and the bother of lower urinary tract symptoms in China: a population-based survey. Int Urogynecol J 2015;26: 911-9.
[31]
Warren JW, Diggs C, Horne L, Greenberg P. Interstitial cystitis/painful bladder syndrome: what do patients mean by 'perceived' bladder pain? Urology 2011;77:309-12.
[32]
Warren JW. Bladder pain syndrome/interstitial cystitis as a functional somatic syndrome. J Psychosom Res 2014;77: 510-5.
Christopher Hartman, Nikhil Gupta, David Leavitt, David Hoenig, Zeph Okeke, Arthur Smith. Advances in percutaneous stone surgery[J]. Asian Journal of Urology, 2015, 2(1): 26
-32
.
